Workshop HBV cure – 3 juillet 2024

11ème séminaire international HBV cure de l’ANRS

8H45 – Welcome & Introduction – 5 min
Fabien Zoulim & Yazdan Yazdanpanah

Functional cure, clinical aspects – 55 min
Chairs: Vincent Leroy, Victor de Ledinghen
The new treatment guidelines for CHB and CHD: are we moving towards functional cure?
Markus Cornberg, Hannovre – 20 min
Impact of HBV DNA integration on functional cure
Patrick Kennedy, London – 20 min

Roundtable discussion – 15 min

Mechanisms of viral persistence – 1h15
Chairs: David Durantel, Hélène Strick-Marchand
Integrative analysis of HBV and immune cells in the liver compartment during antiviral therapy
Oliver Lenz, Janssen Belgium – 20 min
Novel insight in the regulation of cccDNA transcription 
Barbara Testoni, Lyon – 20min
Mechanism of exhaustion of B and T cells and path for functional revovery
Robert Thimme, Freiburg – 20 min

Roundtable discussion – 15 min

11H00 – Coffee break – 20 min

Flash communications / young investigators – 1h30
Chairs: Christine Neuveut, Hugues de Rocquigny
6 talks/young investigators, 15 min each

12H50 – Lunch break – 1h10
 
HDV session – 1h20
Chairs: Julie Lucifora, Vincent Thibault
HDV origin in Homo Sapiens
Frederic Le Gal, Bobigny – 15 min
Insight on HDV – host cell interactions for drug discovery 
Eloi Verrier, Strasbourg – 15 min
Mode of action of Nucleic Acid Polymers in HDV infection
Massimo Levrero, Lyon – 15 min
Intrahepatic decay of HDV during antiviral therapy
Pietro Lampertico, Milan – 15 min
Roundtable discussion – 20 min
 
15H20 – Coffee break – 20 min
 
Drug development 2h20
Chairs: Linda Wittkop, Fabien Zoulim
Results of clinical trials of novel cure strategies
Marc Bourlière, Marseille – 25 min (including 5 min discussion)
CAM inhibitors as backbone treatments for functional cure
Raymond Schinazi, Atlanta – 25 min (including 5 min discussion)
Targeting HBV RNAs with novel ASOs
Guofeng Cheng, AusperBio – 20 min (including 5 min discussion)
Immunological correlates of functional cure
Georg Lauer, Boston – 25 min (including 5 min discussion)
DC-targeting vaccines for HIV and emerging infectious diseases: perspectives for HBV
Yves Levy, Créteil – 25 min (including 5 min discussion)
 
Roundtable discussion: HBV & HDV cure challenges – 20 min
 
18H00 – Conclusions and Farewell – Fabien Zoulim

Plus d'actualités